International Journal of Homoeopathic Sciences
Vol. 6, Issue 4, Part G (2022)
Effectiveness of individualised homoeopathic medicines versus Calcarea Flourica 6x in the treatment of osteoarthritis: An open-label, randomised, pragmatic clinical trial
Author(s):
Dr. Tanya Rai and Dr. Arpan Bhanja
Abstract:
Background: Osteoarthritis is characterized by the destruction of joint cartilage. As the cartilage deteriorates, the bones of the joint begin to push against each other, causing pain and stiffness, often hindering or limiting movement. The joints which bear most of the weight of body is affected by osteoarthritis such as hip, knee, vertebra, and hand, it is a disease of cartilage in which interleukin play an important role.
Materials and methods: This prospective, open label, randomized controlled trial was conducted at Govt. Medical Homeopathic College, Bhopal, and Madhya Pradesh over a period of one year. A total of 60 patients with Osteoarthritis were randomized to receive Individualised Homoeopathic medicine (IH) or Calcarea Flourica 6X (CF) and outcome assessment was done using Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) & Numerical Rating Scale (NRS) scales.
Result: Our study observed that WOMAC score at baseline, there was no significant difference in WOMAC score between IH and CF group (76.23±3.90 vs. 76.06±3.70; p = 0.866).
Conclusion: Both Individualized homeopathic treatment as well as Calcarea Fluor are effective in reducing pain and functional outcomes in patients with osteoarthritis. However, individualized homeopathic treatment provided a better efficacy than Calcarea Fluor.
Pages: 417-424 | 1887 Views 1216 Downloads
How to cite this article:
Dr. Tanya Rai and Dr. Arpan Bhanja. Effectiveness of individualised homoeopathic medicines versus Calcarea Flourica 6x in the treatment of osteoarthritis: An open-label, randomised, pragmatic clinical trial. Int. J. Hom. Sci. 2022;6(4):417-424. DOI: https://doi.org/10.33545/26164485.2022.v6.i4g.690
